• Europe’s response to the Conquering Cancer: Mission Possible report

    02 July 2020

    IDF Europe would like to express its deep disappointment with the Interim report of the Mission Board for Cancer – Conquering Cancer: Mission Possible, published on June 24, by the European Commission Directorate General for Research and Innovation.

  • The deadline for the IDF Europe Youth Leadership Lab is now on 5 July

    01 July 2020

    As part of its ambition to expand youth activities, IDF Europe is launching the first IDF Europe Youth Leadership Lab, an online-based leadership development programme spanning over four months designed for young people living with diabetes.

  • Diabetes chosen as therapeutic area for the pan-EU pilot study of Trials@Home

    26 June 2020

    IDF Europe is one of the consortium partners in an Innovative Medicines Initiative 2 project, Trials@Home. This five-year project, which officially started in September 2019, explores the opportunities of moving clinical trials from the traditional clinic setting to the participant’s immediate surroundings. These so-called Remote Decentralised Clinical Trials (RDCTs) make use of new – digital – innovations and enable participants to visit a clinical trial centre less frequently, if at all. RDCTs aim to help broaden participation in clinical trials from larger, more diverse and remote populations as well as provide results that are more representative, because the data is collected in the daily context of the participant (Real World Evidence).

© 2020 International Diabetes Federation Disclaimer Privacy policy